The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Grant.McQuaker@glasgow.ac.uk
Haemopoietic stem cell transplant and cellular therapy unit, Queen Elizaberth University Hospital, 1345 Govan Road, Glasgow, G51 4TF
Burt, C., Parker, A., McQuaker, G., Copland, M. , Brierley, C., Little, A. and Clark, A. (2014) In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors. Bone Marrow Transplantation, 49(5), pp. 657-663. (doi: 10.1038/bmt.2014.8)
Protheroe, R.E. et al. (2012) The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplantation, 47(1), pp. 88-94. (doi: 10.1038/bmt.2011.12)
Bird, J. et al. (2006) The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study. British Journal of Haematology, 134(4), pp. 385-390.
Pest, E.P., McQuaker, G., Hunter, J.A., Moffat, D. and Stanley, A.J. (2005) Primary hyperparathyroidsm, amyloid and multiple myeloma: an unusual association. Scottish Medical Journal, 50(1), pp. 32-34. (doi: 10.1177/003693300505000114) (PMID:15792389)
Pest, E., McQuaker, G., Hunter, J., Moffat, D. and Stanley, A. (2005) Primary hyperparathyroidsm, amyloid and multiple myeloma: An unusual association. Scottish Medical Journal, 50(1), pp. 32-34.
Faulkner, R. et al. (2004) BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. Blood, 103(2), pp. 428-434.
Branson, K. et al. (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. Journal of Clinical Oncology, 20(19), pp. 4022-4031.
Burt, C., Parker, A., McQuaker, G., Copland, M. , Brierley, C., Little, A. and Clark, A. (2014) In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donors. Bone Marrow Transplantation, 49(5), pp. 657-663. (doi: 10.1038/bmt.2014.8)
Protheroe, R.E. et al. (2012) The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplantation, 47(1), pp. 88-94. (doi: 10.1038/bmt.2011.12)
Bird, J. et al. (2006) The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study. British Journal of Haematology, 134(4), pp. 385-390.
Pest, E.P., McQuaker, G., Hunter, J.A., Moffat, D. and Stanley, A.J. (2005) Primary hyperparathyroidsm, amyloid and multiple myeloma: an unusual association. Scottish Medical Journal, 50(1), pp. 32-34. (doi: 10.1177/003693300505000114) (PMID:15792389)
Pest, E., McQuaker, G., Hunter, J., Moffat, D. and Stanley, A. (2005) Primary hyperparathyroidsm, amyloid and multiple myeloma: An unusual association. Scottish Medical Journal, 50(1), pp. 32-34.
Faulkner, R. et al. (2004) BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. Blood, 103(2), pp. 428-434.
Branson, K. et al. (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. Journal of Clinical Oncology, 20(19), pp. 4022-4031.